IL17A and neoplasm: MDSC-derived IL-1β induces IL-17 secretion by CD4+ T cells leading to curtailed anti-tumor effect of 5-FU against several kinds of tumors including lymphoma, breast cancer, melanoma, and lung cancer [120].